ENDRA Life Sciences Inc. (NDRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.57M |
| Enterprise Value | 3.3M |
| P/E Ratio | -0.75 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.74 |
| Return On Equity | -2.25 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -6.87M |
| Net Income | -7.03M |
| Diluted EPS | -8.93 |
Balance Sheet
| Total Cash | 1.74M |
| Total Cash/Share | 1.31 |
| Total Debt | 429,274 |
| Total Debt/Equity | 0.07 |
| Current Ratio | 7.1 |
| Book Value Per Share | 4.77 |
Price History
| 52-Week Change | -9.43 |
| 52-Week High | 6.95 |
| 52-Week Low | 2.96 |
| Moving Average 50 Days | 5.39 |
| Moving Average 200 Days | 4.8 |
Statistics
| Average Volume | 31,565 |
| Shares Outstanding | 1.5M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | November 07, 2024 |
AD
